Resveratrol and Redox Regulation in Cardiovascular Disease Across the Life Course: Mechanistic and Translational Perspectives
Antioxidants · 20.04.2026 · 15 (4) · 509
DOI: 10.3390/antiox15040509 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Antioxidants, online erschienen am 20.04.2026. Verfasst von Chien-Ning Hsu und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung 801, Taiwan. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 209 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Kaohsiung Chang Gung Memorial Hospital, Taiwan, Kaohsiung Chang Gung Memorial Hospital, National Science and Technology Council, Taiwan.
Abstract (Originalsprache)
Resveratrol (RSV), a bioactive polyphenol, has emerged as a pleiotropic modulator within the integrated pathophysiology of cardiovascular disease (CVD) across the life course. Effective CVD management requires a transition from organ-centric frameworks to systems-level models that acknowledge dynamic crosstalk among metabolic, renal, and cardiovascular networks. Oxidative stress constitutes a central unifying axis in this interconnected biology, propagating cross-organ injury from early developmental stages onward. Mechanistically, RSV acts as a redox-responsive gene regulator by activating the Nrf2–ARE pathway, restoring nitric oxide bioavailability, and orchestrating SIRT1, AMPK, and NF-κB signaling to recalibrate mitochondrial function, inflammatory tone, and endothelial integrity. Within the Developmental Origins of Health and Disease (DOHaD) paradigm, RSV exhibits reprogramming potential that attenuates the intergenerational transmission of hypertension, kidney disease, and metabolic dysfunction. Although clinical translation is constrained by limited bioavailability and rapid metabolism, advanced delivery systems and artificial intelligence-enabled optimization strategies provide promising avenues to enhance therapeutic precision and scalability. This narrative review integrates mechanistic and translational insights to position RSV as a systems-oriented life-course intervention with sustained and intergenerational relevance in CVD.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmacy, Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung 801, Taiwan.
- Department of Pharmacy, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung 833, Taiwan.
- School of Pharmacy, Kaohsiung Medical University, Kaohsiung 807, Taiwan.
- Department of Pediatrics, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung 833, Taiwan.
- College of Medicine, Chang Gung University, Taoyuan 333, Taiwan.
- Doctoral Program of Clinical and Experimental Medicine, National Sun Yat-Sen University, Kaohsiung 804, Taiwan.
ORCID-Profile: Chien-Ning Hsu, You-Lin Tain
Förderung
- Kaohsiung Chang Gung Memorial Hospital, Taiwan
- Kaohsiung Chang Gung Memorial Hospital
- National Science and Technology Council, Taiwan
Zitieren
APA
Hsu, C. N., & Tain, Y. L. (2026). Resveratrol and Redox Regulation in Cardiovascular Disease Across the Life Course: Mechanistic and Translational Perspectives. Antioxidants, 15(4), 509. https://doi.org/10.3390/antiox15040509
Vancouver
Hsu CN, Tain YL. Resveratrol and Redox Regulation in Cardiovascular Disease Across the Life Course: Mechanistic and Translational Perspectives. Antioxidants. 2026;15(4):509. doi:10.3390/antiox15040509
BibTeX
@article{Hsu2026,
author = {Hsu, Chien-Ning and Tain, You-Lin},
title = {Resveratrol and Redox Regulation in Cardiovascular Disease Across the Life Course: Mechanistic and Translational Perspectives},
journal = {Antioxidants},
year = {2026},
volume = {15},
number = {4},
pages = {509},
doi = {10.3390/antiox15040509}
}
EUVIMED